Psychemedics Corp.

  • Market Cap: Micro Cap
  • Industry: Miscellaneous
  • ISIN: US7443752057
USD
1.95
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Psychemedics Corp. stock-summary
stock-summary
Psychemedics Corp.
Miscellaneous
Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment. The Company is in the business of performing drug testing and reporting the results thereof. The Company's drug testing services include training for collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit tested of samples. The Company's primary application of its technology is as a testing service that analyzes hair samples for the presence of certain drugs of abuse. The Company's tests provide information that indicates the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug use over a longer period of time.
Company Coordinates stock-summary
Company Details
125 Nagog Park Ste 200 , ACTON MA : 01720-3451
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 6 Schemes (1.52%)

Foreign Institutions

Held by 1 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Raymond Kubacki
Chairman of the Board, President, Chief Executive Officer
Mr. A. Clinton Allen
Independent Director
Mr. Harry Connick
Independent Director
Mr. Walter Tomenson
Independent Director
Mr. Fred Weinert
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
4 Million
(Quarterly Results - Dec 2024)
Net Profit:
0 Million
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 15 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.14

stock-summary
Return on Equity

-36.24%

stock-summary
Price to Book

2.93